Business Context and Reporting Period
Company: Capricor Therapeutics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 10, 2017
Reporting Period: Second Quarter ended June 30, 2017
This filing serves as a notification that the Company issued a press release announcing its financial results for the quarter ended June 30, 2017, and provided a corporate update via an investor presentation.
Key Financial Metrics
The provided text is a cover document (Form 8-K) referencing external exhibits for detailed data. It does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity.
- Revenue/Profit/Cash Flow: Not provided in this text; contained in Exhibit 99.1 (Press Release).
- Debt/Liquidity: Not provided in this text; contained in Exhibit 99.1 (Press Release).
Material Changes
The filing text does not detail specific material changes versus the prior comparable period. It only indicates that such results were announced in the attached press release (Exhibit 99.1).
Guidance, Outlook, and Management Commentary
Management Commentary: The Company provided a "Corporate Update" alongside the financial results.
Investor Presentation: An investor presentation (Exhibit 99.2) was furnished for review during the earnings release conference call on August 10, 2017.
Legal Disclaimer: The information in Item 2.02 and Item 7.01, including the press release and presentation, is furnished and not deemed filed for purposes of Section 18 of the Exchange Act, nor is it incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q2 2017 financial figures (revenue, net loss, cash position).
- Review Exhibit 99.2 (Corporate Update Presentation) for strategic outlook and operational milestones.
- Verify the date of the earnings conference call (August 10, 2017) for any verbal guidance not captured in the written exhibits.
- Confirm the status of the Company as an emerging growth company (indicated as checked in the filing).